Elite Pharmaceuticals

(OTC) ELTP

Current Price$0.35

Market Cap$375.33M

Since IPO (1998)-83%

5 Year+522%

1 Year-18%

1 Month-8%

Elite Pharmaceuticals Financials at a Glance

Market Cap

$375.33M

Revenue (TTM)

$140.12M

Net Income (TTM)

$43.41M

EPS (TTM)

$0.02

P/E Ratio

15.99

Dividend

$0.00

Beta (Volatility)

0.45 (Low)

Dividend

$0.00

Beta (Volatility)

0.45 (Low)

Price

$0.35

Volume

440,700

Open

$0.34

Price

$0.35

Volume

440,700

Open

$0.34

Previous Close

$0.35

Daily Range

$0.34 - $0.36

52-Week Range

$0.34 - $0.82

Dividend

$0.00

Beta (Volatility)

0.45 (Low)

Price

$0.35

Volume

440,700

Open

$0.34

Previous Close

$0.35

Daily Range

$0.34 - $0.36

52-Week Range

$0.34 - $0.82

ELTP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Elite Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Nasrat A. Hakim

Website

www.elitepharma.com

Headquarters

Northvale, NJ 07647, US

ELTP Financials

Key Financial Metrics (TTM)

Gross Margin

51%

Operating Margin

36%

Net Income Margin

31%

Return on Equity

74%

Return on Capital

44%

Return on Assets

34%

Earnings Yield

6.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$375.33M

Shares Outstanding

1.08B

Volume

440.70K

Avg. Volume

679.06K

Financials (TTM)

Gross Profit

$40.09M

Operating Income

$19.60M

EBITDA

$2.84M

Operating Cash Flow

$7.46M

Capital Expenditure

$2.53M

Free Cash Flow

$4.93M

Cash & ST Invst.

$11.32M

Total Debt

$10.91M

Elite Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$31.59M

+119.9%

Gross Profit

$12.95M

+111.7%

Gross Margin

41.01%

N/A

Market Cap

$375.33M

N/A

Market Cap/Employee

$5.86M

N/A

Employees

N/A

Net Income

$18.59M

+270.7%

EBITDA

$9.52M

+194.4%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Net Cash

$13.88M

+581.2%

Accounts Receivable

$48.53M

+163.0%

Inventory

$25.10M

+24.5%

Long Term Debt

$6.10M

+0.7%

Short Term Debt

$1.12M

-78.2%

Return on Assets

34.34%

N/A

Return on Invested Capital

44.23%

N/A

Free Cash Flow

$5.48M

-415.6%

Operating Cash Flow

$5.28M

-396.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BOIRFBoiron S.A.

BOIRFBoiron S.A.$30.00+0.00%

AGYTFAllergy Therapeutics plc

AGYTFAllergy Therapeutics plc$0.11+0.00%

ABSCFAB Science S.A.

ABSCFAB Science S.A.$1.37+0.00%

GLASFGlass House Brands Inc.

GLASFGlass House Brands Inc.$9.67+0.42%

BPMUFBasilea Pharmaceutica AG

BPMUFBasilea Pharmaceutica AG$69.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

SOUNSoundHound AI

SOUNSoundHound AI$9.56+0.20%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

Questions About ELTP

What is the current price of Elite Pharmaceuticals?

Elite Pharmaceuticals is trading at $0.35 per share.

What is the 52-week range for Elite Pharmaceuticals?

Over the past 52 weeks, Elite Pharmaceuticals has traded between $0.34 and $0.82.

How much debt does Elite Pharmaceuticals have?

As of the most recent reporting period, Elite Pharmaceuticals reported total debt of $6.06M.

How much cash does Elite Pharmaceuticals have on hand?

Elite Pharmaceuticals reported $21.09M in cash and cash equivalents in its most recent financial results.

What is Elite Pharmaceuticals’s dividend yield?

Elite Pharmaceuticals does not currently have a dividend yield.

Elite Pharmaceuticals

Elite Pharmaceuticals Financials at a Glance

ELTP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Elite Pharmaceuticals

ELTP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Elite Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ELTP

What is the current price of Elite Pharmaceuticals?

What is the 52-week range for Elite Pharmaceuticals?

How much debt does Elite Pharmaceuticals have?

How much cash does Elite Pharmaceuticals have on hand?

What is Elite Pharmaceuticals’s dividend yield?

Premium Investing Services